ATG16L1 and NOD2 polymorphisms enhance phagocytosis in monocytes of Crohn’s disease patients

Figure 2 Percentage of phagocytic cells in inflammatory bowel disease patients patients and healthy controls. A: Percentages of active granulocytes are comparable between both groups; B: Significantly higher amount of active phagocytic monocytes was found in the inflammatory bowel disease (IBD) patient group compared to healthy controls (P = 0.0408), ^aP < 0.05 vs HC group; C: Crohn’s disease (CD) patients show a significantly higher percentage of active phagocytic monocytes compared to healthy controls; D, E: This was not seen when compared to ulcerative colitis (UC) patients. Bars represent means.